Growth hormone increases beta-cell proliferation in transplanted human and fetal rat islets

Journal of the Pancreas

Volumn 10, Issue 3, 2009, Pages 242-248

  Höglund, Erika ^a   Mattsson, Göran ^a   Tyrberg, Björn ^a   Andersson, Arne ^a   Carlsson, Carina ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cell proliferation; Human growth hormone; Insulin secreting cells; Islets of langerhans; Transplantation

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; INSULIN; THYMIDINE;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BODY WEIGHT; C57BL MOUSE; CELL ISOLATION; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FETUS; GLUCOSE OXIDATION; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROSCOPY; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS TRANSPLANTATION; RAT; WEIGHT GAIN; ANIMAL; BLOOD; CELL DIVISION; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; FEMALE; FETAL TISSUE TRANSPLANTATION; GLUCOSE BLOOD LEVEL; GRAFT SURVIVAL; METABOLISM; MIDDLE AGED; NUDE MOUSE; ORGAN CULTURE TECHNIQUE; PANCREAS ISLET TRANSPLANTATION; PHYSIOLOGY; PREGNANCY; SPRAGUE DAWLEY RAT; TRANSPLANTATION; XENOGRAFT;

ADULT; AGED; ANIMALS; BLOOD GLUCOSE; CELL DIVISION; CELL SURVIVAL; FEMALE; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, INBRED C57BL; MICE, NUDE; MIDDLE AGED; ORGAN CULTURE TECHNIQUES; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; TRANSPLANTATION, HETEROLOGOUS; YOUNG ADULT;

EID: 68149137267     PISSN: None     EISSN: 15908577     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54:2060-9.
2. Bennet W, Sundberg B, Groth CG, Brendel MD, Brandhorst D, Brandhorst H, et al. Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 1999; 48:1907-14.
3. Moberg L, Johansson H, Lukinius A, Berne C, Foss A, Källen R, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002; 360:2039-45.
4. Sandler S, Andersson A, Korsgren O, Tollemar J, Petersson B, Groth CG, Hellerström C. Tissue culture of human fetal pancreas: growth hormone stimulates the formation and insulin production of islet-like cell clusters. J Clin Endocrinol Metab 1987; 65:1154-8.
5. Nielsen JH, Galsgaard ED, Møldrup A, Friedrichsen BN, Billestrup N, Hansen JA, et al. Regulation of beta-cell mass by hormones and growth factors. Diabetes 2001; 50:S25-9.
6. Brelje TC, Sorenson RL. The physiological roles of prolactin, growth hormone, and placental lactogen in the regulation of islet b-cell proliferation. In: Pancreas Regeneration (ed. Nora Sarvetnick) Landes Company Biomedical Publishers pg 1-23, 1997.
7. Asfari M, De W, Postel-Vinay MC, Czernichow P. Expression and regulation of growth hormone (GH) and prolactin (PRL) receptors in a rat insulin producing cell line (INS-1). Mol Cell Endocrinol 1995; 107:209-14.
8. Billestrup N, Martin JM. Growth hormone binding to specific receptors stimulates growth and function of cloned insulin-producing rat insulinoma RIN-5AH cells. Endocrinology 1985; 116:1175-81.
9. Møldrup A, Petersen ED, Nielsen JH. Effects of sex and pregnancy hormones on growth hormone and prolactin receptor gene expression in insulin-producing cells. Endocrinology 1993; 133:1165-72.
10. Hellerström CH, Lewis NJ, Borg H, Johnson R, Fréinkel N. Method for large-scale isolation of pancreatic islets by tissue culture of fetal rat pancreas. Diabetes 1979; 28:769-76.
11. Heding LG. Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 1972; 8:260-6.
12. Swenne I, Hill DJ, Strain AJ, Milner RD. Growth hormone regulation of somatomedin C/insulin-like growth factor I production and DNA replication in fetal rat islets in tissue culture. Diabetes 1987; 36:288-94.
13. Svensson C. Effects of growth hormone in vitro on the glucose metabolism of fetal rat islet beta-cells. J Mol Endocrinol 1996; 17:131-8.
14. Yuen K, Ong K, Husbands S, Chatelain P, Fryklund L, Gluckman P, et al. The effects of short-term administration of two low doses versus the standard GH replacement dose on insulin sensitivity and fasting glucose levels in young healthy adults. J Clin Endocrinol Metab 2002; 87:1989-95.
15. Martha PM Jr, Rogol AD, Blizzard RM, Shaw MA, Baumann G. Growth hormone-binding protein activity is inversely related to 24-hour growth hormone release in normal boys. J Clin Endocrinol Metab 1991; 73:175-81.
16. Neely RD, Rooney DP, Bell PM, Bell NP, Sheridan B, Atkinson AB, Trimble ER. Influence of growth hormone on glucose-glucose 6-phosphate cycle and insulin action in normal humans. Am J Physiol 1992; 263:E980-97.
17. Fowelin J, Attvall S, Lager I, Bengtsson BA. Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism 1993; 42:1443-7.
18. Adamson U. On the diabetogenic effect of growth hormone in man: effects of growth hormone of glucagon and insulin secretion. Eur J Clin Invest 1981; 11(2 Suppl 1):115-9.
19. Adamson U, Efendic S. Insulin-like and diabetogenic effects of growth hormone in healthy subjects, diabetics, and low insulin responders. J Clin Endocrinol Metab 1979; 49:456-61.
20. Adamson U, Cerasi E. Acute suppressive effect of human growth hormone on basal insulin secretion in man. Acta Endocrinol (Copenh) 1975; 79:474-82.
21. Fineberg SE, Merimee TJ. Acute metabolic effects of human growth hormone. Diabetes 1974; 23:499-504.
22. Tydén G, Berg U, Reinholt F. Acute renal graft rejection after treatment with human growth hormone. Lancet 1990; 336:1455-6.
23. Fine RN, Yadin O, Moulten L, Nelson PA, Boechat MI, Lippe BH. Extended recombinant human growth hormone treatment after renal transplantation in children. J Am Soc Nephrol 1992; 2:S274-83.
24. Panayotatos N, Radziejewska E, Acheson A, Somogyi R, Thadani A, Hendrickson WA, McDonald NQ. Localization of functional receptor epitopes on the structure of ciliary neurotrophic factor indicates a conserved, function-related epitope topography among helical cytokines. J Biol Chem 1995; 270:14007-14.
25. Tönshoff B, Haffner D, Mehls O, Dietz M, Ruder H, Blum WF, et al. Efficacy and safety of growth hormone treatment in short children with renal allografts: three year experience. Members of the German Study Group for Growth Hormone Treatment in Children with Renal Allografts. Kidney Int 1993; 44:199-207.
26. Fine RN, Sullivan EK, Kuntze J, Blethen S, Kohaut E. The impact of recombinant human growth hormone treatment during chronic renal insufficiency on renal transplant recipients. J Pediatr 2000; 136:376-82.
27. Guest G, Bérard E, Crosnier H, Chevallier T, Rappaport R, Broyer M. Effects of growth hormone in short children after renal transplantation. French Society of Pediatric Nephrology. Pediatr Nephrol 1998; 12:437-46.
28. Maxwell H, Dalton RN, Nair DR, Turner C, Saunders AJ, Rigden SP, Rees L. Effects of recombinant human growth hormone on renal function in children with renal transplants. J Pediatr 1996; 128:177-83.
29. Mentser M, Breen TJ, Sullivan EK, Fine RN. Growth-hormone treatment of renal transplant recipients: the National Cooperative Growth Study experience - a report of the National Cooperative Growth Study and the North American Pediatric Renal Transplant Cooperative Study. J Pediatr 1997; 131:S20-24.
30. Mylonas PG, Matsouka PT, Papandoniou EV, Vagianos C, Kalfarentzos F, Alexandrides TK. Growth hormone and insulin-like growth factor I protect intestinal cells from radiation induced apoptosis. Mol Cell Endocrinol 2000; 160:115-22.
31. Jeay S, Sonenshein GE, Kelly PA, Postel-Vinay MC, Baixeras E. Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-kappaB and phosphatidylinositol 3-kinase. Endocrinology 2001; 142:147-56.
32. Jeay S, Sonenshein GE, Postel-Vinay MC, Baixeras E. Growth hormone prevents apoptosis through activation of nuclear factor-kappaB in interleukin-3-dependent Ba/F3 cell line. Mol Endocrinol 2000; 14:650-61.